Bio Osmo Berhad:企業の戦略・SWOT・財務情報

◆英語タイトル:Bio Osmo Berhad - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C1044
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:マレーシア
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Bio Osmo Berhad – Strategy, SWOT and Corporate Finance Report
Summary

Bio Osmo Berhad – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Bio Osmo Berhad (BOB or ‘the company’) is an investment holding company that produces, distributes and markets bottled water and other beverages, through its subsidiary, Amshore Holdings Sdn Bhd. The company markets its products under YES 1968 brand name. BOB operates bottling plant in Mukim Minyak Beku, Johor, Malaysia. The company also carries out management and operation of hotels and resort properties development and investment, through its subsidairy, Intra Magnum Sdn Bhd. BOB sells its products through wholesalers and agents in Malaysia and Singapore. BOB is headquartered in Kuala Lumpur, Malaysia.

Scope

- Detailed information on Bio Osmo Berhad required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Bio Osmo Berhad in the form of a SWOT analysis
- An in-depth view of the business model of Bio Osmo Berhad including a breakdown and examination of key business segments
- Intelligence on Bio Osmo Berhad’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Bio Osmo Berhad, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Bio Osmo Berhad and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Bio Osmo Berhad as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Bio Osmo Berhad’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Bio Osmo Berhad: Company Overview 7
Bio Osmo Berhad: Overview and Key Facts 7
Bio Osmo Berhad: Overview 7
Bio Osmo Berhad: Key Facts 7
Bio Osmo Berhad: Key Employees 9
Bio Osmo Berhad: Key Employee Biographies 10
Bio Osmo Berhad: Major Products and Services 11
Bio Osmo Berhad: Company History 12
Bio Osmo Berhad: Locations and Subsidiaries 13
Bio Osmo Berhad: Key Competitors 14
Bio Osmo Berhad: Company Analysis 15
Bio Osmo Berhad: Business Description 15
Bio Osmo Berhad: SWOT Analysis 16
Bio Osmo Berhad: SWOT Overview 16
Bio Osmo Berhad: Strengths 16
Bio Osmo Berhad: Weaknesses 16
Bio Osmo Berhad: Opportunities 17
Bio Osmo Berhad: Threats 17
Bio Osmo Berhad: Corporate Financial Deals Activity 19
Bio Osmo Berhad: Financial Deals Overview 19
Bio Osmo Berhad: Targets and Partners 21
Bio Osmo Berhad: Top Deals 2014 – 2018YTD* 22
Bio Osmo Berhad: Advisors 23
Bio Osmo Berhad: Top Financial Advisors 23
Bio Osmo Berhad: Mergers and Acquisitions 24
Bio Osmo Berhad: Capital Raising 25
Appendix 26
Contact Us 26
Methodology 26
About MarketLine 27

List of Tables
Table 1: Bio Osmo Berhad: Key Facts
Table 2: Bio Osmo Berhad: Key Employees
Table 3: Bio Osmo Berhad: Locations and Subsidiaries
Table 4: Bio Osmo Berhad: Key Competitors
Table 5: Bio Osmo Berhad: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Bio Osmo Berhad: M&A Activity by Geography (TTM*)
Table 7: Bio Osmo Berhad: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Bio Osmo Berhad: M&A Average Deal Size - Value (US$m)
Table 9: Bio Osmo Berhad: Targets and Partners
Table 10: Bio Osmo Berhad: Top Deals 2014 - 2018YTD*
Table 11: Bio Osmo Berhad: Financial Advisor Ranking by Value (US$m)
Table 12: Bio Osmo Berhad: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Bio Osmo Berhad: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Bio Osmo Berhad: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 15: Bio Osmo Berhad: Capital Raising by Deal Type (2014 - YTD*2018)

List of Figures
Figure 1: Bio Osmo Berhad: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Bio Osmo Berhad: M&A Activity by Geography (TTM*)
Figure 3: Bio Osmo Berhad: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Bio Osmo Berhad: M&A Average Deal Size - Value (US$m)
Figure 5: Bio Osmo Berhad: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Bio Osmo Berhad: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Bio Osmo Berhad: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 8: Bio Osmo Berhad: Capital Raising by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Bio Osmo Berhad:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Leonardo SpA (LDO):企業の財務・戦略的SWOT分析
    Leonardo SpA (LDO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Otsuka Pharmaceutical Factory Inc-製薬・医療分野:企業M&A・提携分析
    Summary Otsuka Pharmaceutical Factory Inc (Otsuka), a subsidiary of Otsuka Holdings Co Ltd is a provider of parenteral and enteral nutrition products. The company’s enteral nutrition products supplies nutrients such as glucose, proteins, fats, electrolytes, and vitamin. It offers over the counter pr …
  • Softship AG:企業の戦略的SWOT分析
    Softship AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Lycera Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Lycera Corp (Lycera) is a biopharmaceutical company that focuses on the development of oral immune modulators for the treatment of patients with autoimmune diseases and cancer. The company’s pipeline products include LYC-55716, an oral retinoic acid-related orphan receptor gamma (RORgamma) a …
  • Steinhoff International Holdings NV (SNH):企業の財務・戦略的SWOT分析
    Steinhoff International Holdings NV (SNH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Endonovo Therapeutics Inc (ENDV):製薬・医療:M&Aディール及び事業提携情報
    Summary Endonovo Therapeutics Inc (Endonovo Therapeutics) is a commercial stage development company that offers non-invasive medical devices and equipment. The company’s products include Electroceutical Therapy a FDA-Cleared for the palliative treatment of pain and post-surgical edema and CE Marked …
  • Santen Pharmaceutical Co Ltd (4536):医療機器:M&Aディール及び事業提携情報
    Summary Santen Pharmaceutical Co Ltd (Santen) focuses on the research, development, manufacture and marketing of pharmaceutical products and medical devices. Its product portfolio includes prescription ophthalmic products for bacterial conjunctivitis, glaucoma, dry eye, Inflammation and others; OTC …
  • Cabela’S Inc:企業の戦略・SWOT・財務分析
    Cabela'S Inc - Strategy, SWOT and Corporate Finance Report Summary Cabela'S Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Faron Pharmaceuticals Oy (FARN):医療機器:M&Aディール及び事業提携情報
    Summary Faron Pharmaceuticals Oy (Faron) is a clinical stage biopharmaceutical company that conducts clinical stage drug discovery and development. The company's pipeline products focus on cute organ traumas, vascular damage and cancer immunotherapy. It offers Traumakine, that helps to prevent vascu …
  • Spectrum Pharmaceuticals Inc (SPPI):企業の財務・戦略的SWOT分析
    Spectrum Pharmaceuticals Inc (SPPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Sony Financial Holdings Inc.:企業の戦略・SWOT・財務分析
    Sony Financial Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Sony Financial Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Polyus Gold International Limited:企業の戦略・SWOT・財務情報
    Polyus Gold International Limited - Strategy, SWOT and Corporate Finance Report Summary Polyus Gold International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Jellagen Pty Ltd-医療機器分野:企業M&A・提携分析
    Summary Jellagen Pty Ltd (Jellagen) is a provider of medical grade collagen products. The company’s products offer medical grade collagen supplied in the form of hydragel used in wound dressing, soft tissue regeneration, tissue engineering and haemostats. Its product pipeline offer scaffolds which c …
  • Ergon Inc:企業の戦略・SWOT・財務情報
    Ergon Inc - Strategy, SWOT and Corporate Finance Report Summary Ergon Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Taiwan Liposome Co Ltd (4152):企業の財務・戦略的SWOT分析
    Summary Taiwan Liposome Co Ltd (TLC) is a clinical-stage pharmaceutical company, which develops and commercializes novel nanomedicines based on drug delivery technology platform. The company’s pipeline products include TLC599, TLC590, TLC399 and TLC178. Its TLC 178 is used for the treatment of adult …
  • General Re Corporation:企業の戦略的SWOT分析
    General Re Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • IBIDEN Co Ltd (4062):企業の財務・戦略的SWOT分析
    IBIDEN Co Ltd (4062) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sun BioPharma Inc (SNBP):製薬・医療:M&Aディール及び事業提携情報
    Summary Sun BioPharma Inc (Sun BioPharma), formerly Cimarron Medical Inc is a biopharmaceutical company that develops disruptive therapeutics for treatment of pancreatic cancer and pancreatitis. The company’s pipeline products include SBP-101, SBP-102 and SBP-103. Its SBP-101 produces superior anti- …
  • Brokk AB:企業の戦略的SWOT分析
    Brokk AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Petkim Petrokimya Holding AS (PETKM):企業の財務・戦略的SWOT分析
    Summary Petkim Petrokimya Holding AS (Petkim Petrokimya), a subsidiary of State Oil Company of the Azerbaijan Republic, is a chemical company. Its products portfolio includes propylene, acrylonitrile, ethylene, polyvinyl chloride, aromatics, polypropylene, sodium hydroxide, diethylene glycol, polyme …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆